Population-based data have shown elevated plasma AVP levels and its surrogate marker copeptin [10] in various types of heart failure, acute myocardial infarction, diabetes development, and hypertension [11,12,194,195,196,197]. This evidence concerns the gene AVP and acute myocardial infarction.